FREE WEBINAR
New Approach for Optimizing Antifungal Therapy:
Two-Step Rapid Fungal Diagnostic by PCR/NGS
December 4, 2024 at 2pm ET
60-Minute Webinar Sponsored By
.png){kind=logo}
Join our webinar to discover an innovative 24-hour fungal diagnostic tool that identifies molds and yeasts with precision!
Early detection is vital for successfully treating life-threatening invasive fungal and mold infections. Traditional culture-based methods can be challenging, time-consuming, and costly, leading to delays in organism identification and the timely administration of critical antifungal therapies. The emergence of advanced PCR/NGS technologies has set a new gold standard for rapid identification and diagnosis, ensuring timely and appropriate patient care.
MicroGenDX is a leader in Next-Generation DNA Sequencing, delivering enhanced sensitivity compared to standard culture methods. This innovative 2-step PCR/NGS process enables rapid and precise diagnosis of fungal infections, achieving 99% accuracy within just 24 - 48 hours. This invaluable tool streamlines the identification of complex infections, ensuring that patients receive targeted treatment from the outset, leading to quicker resolutions and allowing for the rapid de-escalation of costly antifungal medications.
This free 60 minute webinar, sponsored by MicroGenDX and hosted by Dark Daily, is your chance to learn about NGS tools of the future for fungal diagnostics.
Please join us on Wednesday, December 4, 2024, at 2:00 pm ET.
Key Learnings:
During this webinar, you will:
- Explore an innovative 2-step PCR/NGS diagnostic tool designed for rapid and sensitive fungal diagnosis.
- Analyze the prevalence of pathogenic yeasts and molds and their effects on current diagnostic practices.
- Utilize an optimized fungal diagnostic tool that promotes effective antibiotic stewardship.
- See how organizations have successfully implemented these strategies to improve turnaround times and patient care.
Expert Speakers
Jose Alexander, MD
Director or the Microbiology Laboratories
Advent Health
Dr. Jose Alexander is a Medical and Public Health Microbiologist graduated from the Central University of Venezuela. He is certified by the American Board of Medical Microbiology (ABMM) and is a Fellow of the Canadian College of Microbiologists. Dr. Alexander is also recognized as a Specialist in Microbiology and Molecular Biology by the American Society for Clinical Pathologist (ASCP). Dr. Alexander is board certified in Infection Control and Epidemiology (CBIC) as well as a Medical Affairs Specialist by the American Council for Medical Affairs' (ACMA). Dr. Alexander is the Director or the Microbiology Laboratories at AdventHealth Orlando, where he has implemented rapid and comprehensive antimicrobial resistance (AMR) protocols, rapid and cost-effective whole genome sequencing solutions, and laboratory optimization through dashboard implementation. At present, Dr. Alexander's areas of interest include antimicrobial resistance, next-generation sequencing (NGS), epidemiology, and data-driven laboratory optimization.
Nicholas Sanford
Assistant Laboratory Director
MicroGenDX
Nicholas Sanford has been working as a clinical laboratorian and assistant laboratory director after graduating from Texas Tech University with a BS in Plant Biotechnology and a PhD in Biological Sciences in 2015. He was professionally certified by Stanford University in Genetics and Genomics and is a Board Certified Medical Affairs Specialist. Dr. Sanford's research interests are in molecular assay design and determining the clinical utility of diagnostic assays.
Who should attend?
- Lab Directors & Managers
- Infectious Diseases Physicians
- Critical care Physicians
- Infectious Diseases Pharmacists
- Microbiologists
Hosted By
